Tibet Weixinkang Medicine Co Ltd (603676)

Currency in CNY
12.48
-0.24(-1.89%)
Closed·
603676 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
12.4312.72
52 wk Range
7.2214.94
Key Statistics
Bid/Ask
12.48 / 12.49
Prev. Close
12.72
Open
12.65
Day's Range
12.43-12.72
52 wk Range
7.22-14.94
Volume
10.66M
Average Volume (3m)
9.73M
1-Year Change
55.07%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603676 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Tibet Weixinkang Medicine Co Ltd Company Profile

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases, and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is based in Lhasa, China.

Employees
689
Market
China

Compare 603676 to Peers and Sector

Metrics to compare
603676
Peers
Sector
Relationship
P/E Ratio
22.9x32.4x−0.5x
PEG Ratio
−4.17−1.030.00
Price/Book
3.7x3.1x2.6x
Price / LTM Sales
4.2x4.5x3.2x
Upside (Analyst Target)
-12.9%42.7%
Fair Value Upside
Unlock5.2%5.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.55%
Dividend Yield
4.93%
Industry Median 1.54%
Annualised payout
0.63
Paid annually
5-Years Growth
+50.02%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.20 / --
Revenue / Forecast
295.81M / --
EPS Revisions
Last 90 days

603676 Income Statement

FAQ

What Stock Exchange Does Tibet Weixinkang Medicine Trade On?

Tibet Weixinkang Medicine is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Tibet Weixinkang Medicine?

The stock symbol for Tibet Weixinkang Medicine is "603676."

What Is the Tibet Weixinkang Medicine Market Cap?

As of today, Tibet Weixinkang Medicine market cap is 5.38B.

What Is Tibet Weixinkang Medicine's Earnings Per Share (TTM)?

The Tibet Weixinkang Medicine EPS (TTM) is 0.55.

When Is the Next Tibet Weixinkang Medicine Earnings Date?

Tibet Weixinkang Medicine will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is 603676 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Tibet Weixinkang Medicine Stock Split?

Tibet Weixinkang Medicine has split 0 times.

How Many Employees Does Tibet Weixinkang Medicine Have?

Tibet Weixinkang Medicine has 689 employees.

What is the current trading status of Tibet Weixinkang Medicine (603676)?

As of 23 Jul 2025, Tibet Weixinkang Medicine (603676) is trading at a price of 12.48, with a previous close of 12.72. The stock has fluctuated within a day range of 12.43 to 12.72, while its 52-week range spans from 7.22 to 14.94.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.